<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04855682</url>
  </required_header>
  <id_info>
    <org_study_id>4184/2021/ODDZ-11156</org_study_id>
    <nct_id>NCT04855682</nct_id>
  </id_info>
  <brief_title>EuroPainClinicsStudy X</brief_title>
  <acronym>EPCS X</acronym>
  <official_title>EuroPainClinicsStudy X (Minimally Invasive Spinal Surgical Approaches)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Europainclinics z.ú.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>R-CLINIC s.r.o.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Faculty Hospital Nitra</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Slovak Academy of Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Bratislava</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Europainclinics z.ú.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Non-interventional, retrospective-prospective cohort study based on the collection of data&#xD;
      and their evaluation after medical procedures: micro-discectomy, endoscopic discectomy, and&#xD;
      hemilaminectomy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this clinical study is to compare the benefits and complications after minimally&#xD;
      invasive spinal procedures in patients with acute lumbosacral radicular syndrome caused by a&#xD;
      herniated disc compressing the spinal neural structures.&#xD;
&#xD;
      The study only works with patient data provided by the outpatient clinic for research&#xD;
      analysis in the EPCS IV clinical study. All patient data are encrypted during collection and&#xD;
      evaluation during the study, and stored in an encrypted database. The data will be evaluated&#xD;
      by an independent institution - The Institute of Measurement of the Slovak Academy of&#xD;
      Sciences.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">July 15, 2021</start_date>
  <completion_date type="Anticipated">April 15, 2024</completion_date>
  <primary_completion_date type="Anticipated">April 15, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fat degeneration of muscles</measure>
    <time_frame>12 months after procedure</time_frame>
    <description>Fat degeneration of musculus erector spinae and multifidus muscles evaluated by comparing the pre-operative current MRI of the lumbosacral spine using the 2-point Dixon Technique and Goutallier classification in each group</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fat degeneration of muscles</measure>
    <time_frame>24 months after procedure</time_frame>
    <description>Fat degeneration of musculus erector spinae and multifidus muscles evaluated by comparing the pre-operative current MRI of the lumbosacral spine using the 2-point Dixon Technique and Goutallier classification in each group</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oswestry disability index (ODI)</measure>
    <time_frame>12 months and 24 months after procedure</time_frame>
    <description>ODI is based on a questionnaire, which includes 10 items, each one has 6 possible answers. Each item is rated from 0 to 5 and the sum of all answers is evaluated on a scale from 0-100, with higher scores meaning more serious symptoms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oswestry disability index (ODI)</measure>
    <time_frame>24 months after procedure</time_frame>
    <description>ODI is based on a questionnaire, which includes 10 items, each one has 6 possible answers. Each item is rated from 0 to 5 and the sum of all answers is evaluated on a scale from 0-100, with higher scores meaning more serious symptoms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>EQ-5D-5L</measure>
    <time_frame>12 months after procedure</time_frame>
    <description>EQ-5D is a standardized questionnaire tool developed by the EuroQol group as a measure of the quality of life linked to health, that can be used in a wide spectrum of health conditions and their treatment. The system has 5 dimensions: mobility, being able to take care of oneself, every-day activities, pain/discomfort and anxiety/depression. Each system can be graded from 1-5, where 1 means no problems in the area and 5 meaning extreme problems. T Changes in the visual analogue scale (VAS) of lower limb pain evaluated on a scale of 0 to 10</description>
  </primary_outcome>
  <primary_outcome>
    <measure>EQ-5D-5L</measure>
    <time_frame>24 months after procedure</time_frame>
    <description>EQ-5D is a standardized questionnaire tool developed by the EuroQol group as a measure of the quality of life linked to health, that can be used in a wide spectrum of health conditions and their treatment. The system has 5 dimensions: mobility, being able to take care of oneself, every-day activities, pain/discomfort and anxiety/depression. Each system can be graded from 1-5, where 1 means no problems in the area and 5 meaning extreme problems. T Changes in the visual analogue scale (VAS) of lower limb pain evaluated on a scale of 0 to 10</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Usage of painkillers before and after the procedures</measure>
    <time_frame>12 months after procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Usage of painkillers before and after the procedures</measure>
    <time_frame>24 months after procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of early and late post-surgery complications</measure>
    <time_frame>12 months after procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of early and late post-surgery complications</measure>
    <time_frame>24 months after procedure</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Back Pain</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <description>Endoscopic discectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <description>Microdisectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C</arm_group_label>
    <description>Hemilaminectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Retrospective observation after 24 months after the spinal procedure</intervention_name>
    <description>Retrospective evaluation of patients before the procedure, and prospective evaluation of patients 24 months after the spinal procedure, comparing the MRI changes and procedure impact on fatty muscle degeneration process</description>
    <arm_group_label>A</arm_group_label>
    <arm_group_label>B</arm_group_label>
    <arm_group_label>C</arm_group_label>
    <other_name>Quality of life</other_name>
    <other_name>MRI description</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Retrospective observation after 12 months after the spinal procedure</intervention_name>
    <description>Retrospective evaluation of the patient status before the procedure, and prospective evaluation of patients for 12 months after the spinal procedure, comparing the MRI changes</description>
    <arm_group_label>A</arm_group_label>
    <arm_group_label>B</arm_group_label>
    <arm_group_label>C</arm_group_label>
    <other_name>Quality of life</other_name>
    <other_name>MRI description</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Prospective evaluation of patients after 12 and 24 months after the spinal procedure</intervention_name>
    <description>Prospective evaluation of patients after 12 and 24 months after the spinal procedure, comparing the MRI changes</description>
    <arm_group_label>A</arm_group_label>
    <arm_group_label>B</arm_group_label>
    <arm_group_label>C</arm_group_label>
    <other_name>Quality of life</other_name>
    <other_name>MRI description</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients after medical procedures: micro-discectomy, endoscopic discectomy, and&#xD;
        hemilaminectomy.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient age 18-60 years&#xD;
&#xD;
          -  first spinal surgery in the areas L1-S1&#xD;
&#xD;
          -  signed informed consent for the participation in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with a history of other back problems (compression fracture, spondylitis,&#xD;
             tumour)&#xD;
&#xD;
          -  patients after repeated spinal surgeries&#xD;
&#xD;
          -  patients with a systemic disease affecting the muscles elite athletes&#xD;
&#xD;
          -  patients who disagree to participate in the study&#xD;
&#xD;
          -  women with a positive pregnancy test or women planning on becoming pregnant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Miroslav Burianek, MD MBA</last_name>
    <role>Study Chair</role>
    <affiliation>clinical monitor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ladislav Kocan, MD PhD</last_name>
    <phone>+421557891100</phone>
    <email>europainclinicsstudy@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Robert Rapcan, MD PhD FIPP</last_name>
    <email>rapcan@europainclinics.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>R - Clinic s.r.o.</name>
      <address>
        <city>Bardejov</city>
        <zip>04011</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ladislav Kočan, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>R - Clinic s.r.o.</name>
      <address>
        <city>Bardejov</city>
        <zip>085 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rapcan Robert, MD FIPP</last_name>
      <phone>+421 948 602 510</phone>
      <email>rapcan@europainclinics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>R - Clinic s.r.o.</name>
      <address>
        <city>Bardejov</city>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Rapčan, MD FIPP</last_name>
    </contact>
    <contact_backup>
      <last_name>Miroslav Burianek, MD MBA</last_name>
    </contact_backup>
    <investigator>
      <last_name>Ladislav Kočan, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Viktor Witkovský, Doc. RNDr. CSc.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miroslav Gajdoš, Doc. MUDr., PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>René Hako, Mgr. MUDr. PhD., MHA, MPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kamil Koleják, MUDr.PhD. MSc.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Slovakia</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 18, 2021</study_first_submitted>
  <study_first_submitted_qc>April 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 22, 2021</study_first_posted>
  <last_update_submitted>May 22, 2021</last_update_submitted>
  <last_update_submitted_qc>May 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>R-CLINIC s.r.o.</investigator_affiliation>
    <investigator_full_name>MUDr. Miroslav Buriánek MBA, MUDr. Robert Rapčan FIPP</investigator_full_name>
    <investigator_title>Clinical Research Manager</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

